A Study of Oral Sapacitabine in Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia
Clinical trial NCT01303796 · COMPLETED
Trial details
- NCT number
- NCT01303796
- Sponsor
- Cyclacel Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2016-12-15
- Enrollment
- 482
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.